| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/04/1999 | EP0932401A1 Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,r)-glycopyrrolate |
| 08/04/1999 | EP0932400A1 Anticonvulsant derivatives useful in treating neuropathic pain |
| 08/04/1999 | EP0932399A1 Water soluble paclitaxel prodrugs |
| 08/04/1999 | EP0932398A1 Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders |
| 08/04/1999 | EP0932397A2 Medicinal aerosol formulations comprising budesonide |
| 08/04/1999 | EP0932396A1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| 08/04/1999 | EP0932393A1 Solid foamed active substance preparations |
| 08/04/1999 | EP0932390A1 Therapeutic liposome composition and method |
| 08/04/1999 | EP0932389A1 Ophthalmic compositions containing a carbonic anhydrase inhibitor and xanthan gum |
| 08/04/1999 | EP0932388A2 Dosage form and method for administering drug |
| 08/04/1999 | EP0932387A1 Skin care compositions containing combinations of compounds for mimicking the effect on skin of retinoic acid |
| 08/04/1999 | EP0857172B1 Phosphorus containing cythesine derivatives |
| 08/04/1999 | EP0854720B1 Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
| 08/04/1999 | EP0848707B1 4-(cycloalkyl)piperidines and 4-(cycloalkylalkyl)-piperidines derivatives, preparation thereof and therapeutical applications thereof |
| 08/04/1999 | EP0814805A4 Process and products for reducing biological fluid levels of a lipid soluble waste |
| 08/04/1999 | EP0810989B1 Novelly substituted dtpa derivatives, metal complexes thereof, pharmaceuticals containing these complexes, diagnostic and therapeutic uses thereof and methods for preparing the complexes and pharmaceuticals |
| 08/04/1999 | EP0808306B1 New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds |
| 08/04/1999 | EP0760601A4 Predicting fetal membrane rupture by mmp-9 activity |
| 08/04/1999 | EP0759027B1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 08/04/1999 | EP0752985B1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 08/04/1999 | EP0748311B1 Therapeutic benzonitriles |
| 08/04/1999 | EP0740653B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 08/04/1999 | EP0737176B1 Process for isomerizing linear olefins to isoolefins |
| 08/04/1999 | EP0701555B1 Indazole derivatives |
| 08/04/1999 | EP0640086B1 MERCAPTOACETYLAMIDO PYRIDAZO[ 1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE |
| 08/04/1999 | EP0628038B1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO [b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION |
| 08/04/1999 | EP0608308B1 Anti-seborrhoeic formulation |
| 08/04/1999 | EP0590026B1 Orally active antiviral compounds |
| 08/04/1999 | EP0585242B1 Wound healing |
| 08/04/1999 | EP0575490B1 GnRH ANALOGS |
| 08/04/1999 | CN1225131A Method for treating amyotrophic lateral sclerosis |
| 08/04/1999 | CN1225098A 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| 08/04/1999 | CN1225097A Novel method for isomerising the 10-methyl radical of erythromycin derivatives |
| 08/04/1999 | CN1225096A Bromotiacumicin compounds |
| 08/04/1999 | CN1225094A Modified form of the R(-)-N-(4,4-di-(3-methylthien-2-yl) but-3-enyl)-nipecotic acid hydrochloride |
| 08/04/1999 | CN1225093A Benzo[g] quinoline derivatives |
| 08/04/1999 | CN1225091A Substituted 1,3-benzodioxoles |
| 08/04/1999 | CN1225087A Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
| 08/04/1999 | CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 08/04/1999 | CN1225083A Calcium receptor-active compounds |
| 08/04/1999 | CN1225082A Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same |
| 08/04/1999 | CN1225014A Methods and compositions for reducing or eliminating post-surgical adhesion formation |
| 08/04/1999 | CN1225013A Non-peptide G-CSF mimetics |
| 08/04/1999 | CN1225012A Therapeutic treatment for cardiovascular diseases |
| 08/04/1999 | CN1225011A Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient |
| 08/04/1999 | CN1225010A Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases |
| 08/04/1999 | CN1225009A Pentafluorobenzenesulfonamides and analogs |
| 08/04/1999 | CN1225007A Cationic virosomes as transfer system for genetic material |
| 08/04/1999 | CN1224720A Tetracylic derivatives, process of preparation and use |
| 08/04/1999 | CN1224718A Thiazole derivatives |
| 08/04/1999 | CN1224715A Cycloalkano-indote and againdole derivatives, process for their preparation and pharmaceutical composition containing the same |
| 08/04/1999 | CN1224714A N-(4-carbamimido-phenyl)-phenylglycinamid derivatives |
| 08/04/1999 | CN1224619A Novel powder compositions |
| 08/04/1999 | CN1224617A External-use medicine for curing various chronic ulcers |
| 08/04/1999 | CN1224611A Method and composition for treatment and prevention of hyperuricemia |
| 08/04/1999 | CN1224610A Ibuprofen compositions |
| 08/04/1999 | CN1224609A Method to control animal ecto-parasites |
| 08/04/1999 | CN1044476C Chelate and preparation thereof |
| 08/04/1999 | CN1044473C Tropone-substituted phenyloxazolidinone antibacterial agents |
| 08/03/1999 | US5932765 Nitromethyl ketones, process for preparing them and compositions containing them |
| 08/03/1999 | US5932749 Asymmetric synthesis of R-α-propyl-piperonyl amine and its analogs |
| 08/03/1999 | US5932742 Chemical intermediate to active antitumor agent |
| 08/03/1999 | US5932734 N-aminoalkylfluorenecarboxamides |
| 08/03/1999 | US5932732 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
| 08/03/1999 | US5932730 Endothelin antagonist |
| 08/03/1999 | US5932728 Antihistamines; antiallergens |
| 08/03/1999 | US5932726 Asymmetric synthesis of benzoxazinones |
| 08/03/1999 | US5932716 Disclosed herein are methods and compositions for identifying morphogen analogs. |
| 08/03/1999 | US5932710 Alkylation, oximination, deblocking |
| 08/03/1999 | US5932624 Containing folic acid and vitamin b12 |
| 08/03/1999 | US5932622 Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid |
| 08/03/1999 | US5932621 Methods of using ajoene for the treatment of tumors |
| 08/03/1999 | US5932619 Protective agent is a dimer of mandelic acid or a dimer of substituted mandelic acid. |
| 08/03/1999 | US5932618 Administering to an animal naphthalene derivatives to inhibit replication of viruses of the herpes family, such as herpes simplex, cytomegalovirus, epstein-barr virus, or human lymphotrophic virus |
| 08/03/1999 | US5932617 Antiscarring agent |
| 08/03/1999 | US5932616 Potent inducers of terminal differentiation and methods of use thereof |
| 08/03/1999 | US5932614 Sulfonic stilbene compounds in the treatment of viral diseases |
| 08/03/1999 | US5932613 Pine root fungal metabolite or analog |
| 08/03/1999 | US5932611 5-amino-2,2-dimethyl-6-(3'-(r,s) amino-4'-hydroxy-butan-1-one)-2,3-dihydro-4h-1-benzopyran-4-on e |
| 08/03/1999 | US5932610 Tumor necrosis factor α (TNF-α) inhibiting pharmaceuticals |
| 08/03/1999 | US5932609 Pharmaceutical composition for inhibiting the growth of cancers |
| 08/03/1999 | US5932607 Imidazole derivatives and process for preparing the same |
| 08/03/1999 | US5932604 Pharmaceutical compositions for the treatment of viral infections |
| 08/03/1999 | US5932603 Orally administering 6-amidino-2-naphthyl4-((4,5-dihydro-1h-imidazol-3-yl-)amino)be nzoate |
| 08/03/1999 | US5932602 Treatment of platelet derived growth factor related disorders such as cancers |
| 08/03/1999 | US5932601 Oxazolidinedione derivatives, their production and use |
| 08/03/1999 | US5932600 Inhibitors of IMPDH enzyme |
| 08/03/1999 | US5932599 4-amino-n-(pyridinyl-4-yl)-benzenesulfonamides as active material treating malaria, bacterial infection, neurological disorders |
| 08/03/1999 | US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 08/03/1999 | US5932597 Anaesthetic formulation |
| 08/03/1999 | US5932595 Antiarthritic agent; multiple sclerosis; osteoporosis; respiratory system disorders; skin disorders; antiulcer agent |
| 08/03/1999 | US5932594 3-substituted piperidine derivative |
| 08/03/1999 | US5932593 Antiserotonin agent |
| 08/03/1999 | US5932592 Quinoline or quinazoline derivatives, their production and use |
| 08/03/1999 | US5932591 C3 substituted trioxanes useful as antiparasitic drugs |
| 08/03/1999 | US5932589 Oral drug |
| 08/03/1999 | US5932587 Heterocyclic-fused pyridines |
| 08/03/1999 | US5932586 Prostaglandin synthase inhibitors |
| 08/03/1999 | US5932585 5-amino-8-phenyl-3h,6h-1,4,5a,8a-tetraazaacenaphthylen-3-ones |
| 08/03/1999 | US5932581 Administering sorbitol dehydrogenase inhibitor |